Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clarvin is a Sweden-based medical technology consulting company focused on regulatory affairs and quality assurance for medical devices and in vitro diagnostics. The company supports clients with compliance strategy, quality management systems, clinical and regulatory documentation, EU and UK representation, and market access preparation across EU, US, and other jurisdictions. Clarvin has been positioned as part of a broader medtech compliance ecosystem alongside Devicia, Limulus Bio, Lea Reg, and Kickfile. In October 2022, Clarvin was acquired by Veranex, expanding Veranex’s regulatory, quality, and clinical capabilities for the global medical device and IVD market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clarvin.